Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle

Journal of Cellular Physiology

Volumn 202, Issue 3, 2005, Pages 839-848

  Toki, Fujio ^a,b   Nanba, Daisuke ^a   Matsuura, Nariaki ^b   Higashiyama, Shigeki ^a,c  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; ZINC FINGER PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELLULAR DISTRIBUTION; CHROMOSOME SEGREGATION; CYTOKINE PRODUCTION; CYTOMETRY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; HUMANS; KERATINOCYTES; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; SUBCELLULAR FRACTIONS; TIME FACTORS; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 12944258682     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20175     Document Type: Article

References (35)

1. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S. 2002. Cardiac hypertrophy is inhibited by antagonizm of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy. Nat Med 8:35-40.
2. Bao J, Wolpowitz D, Role LW, Talmage DA. 2003. Back signaling by the Nrg-1 intracellular domain. J Cell Biol 161:1133-1141.
3. Barna M, Merghob T, Costoya JA, Ruggero D, Branford M, Bergia A, Samori B, Pandolfi PP. 2002. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev Cell 3:499-510.
4. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J. 1999. Nuclear translocation of p42/p44-mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674.
5. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. 1997. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16:1268-1278.
6. Gechtman Z, Alonso JL, Raab G, Ingber DE, Klagsbrun M. 1999. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J Biol Chem 274:28828-28835.
7. Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6:967-980.
8. Hackel PO, Zwick E, Prenzel N, Ullrich A. 1999. Epidermal growth factors: Critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11:184-189.
9. Hashimoto K, Higashiyama S, Asada H, Hashimura E, Kobayashi T, Sudo K, Nakagawa T, Damm D, Yoshikawa K, Taniguchi N. 1994. Heparin-binding EGF-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 269:20060-20066.
10. Higashiyama S. 2004. Metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor and it's pathophysiological roles. Protein Pept Lett (in press).
11. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939.
12. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. 1992. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 267:6205-6212.
13. Higashiyama S, Abraham JA, Klagsbrun M. 1993. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparin sulfate. J Cell Biol 122:933-940.
14. Hirata M, Umata T, Takahashi T, Ohnuma M, Miura Y, Iwamoto R, Mekada E. 2001. Identification of serum factor inducing ectodomain shedding of proHB-EGF and studies of noncleavable mutants of proHB-EGF. Biochem Biophys Res Commun 283:915-922.
15. Hochholdinger F, Baier G, Nogalo A, Bauer B, Grunicke HH, Uberall F. 1999. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH3T3 cells. Mol Cell Biol 19:8052-8056.
16. Ivins S, Pemberton K, Guidez F, Howell L, Krumlauf R, Zelent A. 2003. Regulation of Hoxb2 by APL-associated PLZF protein. Oncogene 22:3685-3697.
17. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, Nanba D, Higashiyama S, Hori M, Klagsbrun M, Mekada E. 2003. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA 100:3221-3226.
18. Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E. 1998. A metalloprotease- disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J 17:7260-7272.
19. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, Lee DC. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22:2704-2716.
20. Kim-Kaneyama J, Nose K, Shibanuma M. 2000. Significance of nuclear relocalization of ERK1/2 in reactivation of c-fos transcription and DNA synthesis in senescent fibroblasts. J Biol Chem 275:20685-20692.
21. Madarame J, Higashiyama S, Kiyota H, Madachi A, Toki F, Shimomura T, Tani N, Oishi Y, Matsuura N. 2003. Transactivation of epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by Bombesin. Prostate 57:187-195.
22. McConnell MJ, Chevallier N, Brekofsky-Fessler W, Giltnane JM, Malani RB, Staut LM, Licht JD. 2003. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell Biol 24:2890-2904.
23. Miyagawa J, Higashiyama S, Kawata S, Inui Y, Tamura S, Yamamoto K, Nishida M, Nakamura T, Yamashita S, Matsuzawa Y, Taniguchi N. 1995. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic palques. J Clin Invest 95:404-411.
24. Nanba D, Higashiyama S. 2004. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor. Cytokine Growth Factor Rev 15:13-19.
25. Nanba D, Mammoto A, Hashimoto K, Higashiyama S. 2003. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol 163:489-502.
26. Nishi E, Prat A, Hospital V, Elenius K, Klagsbrun M. 2001. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J 20:3342-3350.
27. Prober DA, Edgar BA. 2001. Growth regulation by oncogenes - New insights from model organisms. Curr Opin Genet Dev 11:19-26.
28. Raab G, Klagsbrun M. 1997. Heparin-binding EGF-like growth factor. Biochem Biophys Acta 1333:179-199.
29. Tokumaru S, Higashiyama S, Endo T, Nakagawa T, Miyagawa J, Yamamori K, Hanakawa H, Ohmoto H, Yoshino K, Shirakata Y, Matsuzawa Y, Hashimoto K, Taniguchi N. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol 151:209-219.
30. Umata T, Hirata M, Takahashi T, Ryu F, Shida S, Takahashi Y, Tsuneoka M, Miura Y, Masuda M, Horiguchi Y, Mekada E. 2001. A dual signaling cascade that regulates the ectodamain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem 276:30475-30482.
31. Umeda Y, Miyazaki Y, Shiinoki H, Higashiyama S, Nakanishi Y, Hieda Y. 2001. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev Biol 237:202-211.
32. Urbani L, Sherwood SW, Shimke RT. 1995. Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization. Exp Cell Res 219:159-168.
33. Wallasch C, Crabtree JE, Bevec D, Robinson PA, Wagner H, Ullrich A. 2002. Helicobacter pylori-stimulated EGF recptor transactivation requires metalloprotease cleavage of HB-EGF. Biochem Biophys Res Commun 295:695-701.
34. Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, Kimura R, Mizushima H, Moribe H, Higashiyama S, Endoh M, Kaneda Y, Takagi S, Kami S, Takeda N, Yamada G, Mekada E. 2003. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 163:469-475.
35. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxmann S, NasonBurchenal K, Dmitrovsky E, Zelent A, Licht JD. 1999. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18:925-934.